VMP 42209311000001101

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Doxazosin 4mg tablets
BNF code 0205040D0AAACAC
Virtual Therapeutic Moiety Doxazosin
Date identifier became valid 1 Sep 2023
Previous product identifier 318783003
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Doxazosin mesilate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 372508002
Strength value numerator 4.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Doxadura 4mg tablets (Dexcel-Pharma Ltd)
Doxazosin 4mg tablets (A A H Pharmaceuticals Ltd)
Doxazosin 4mg tablets (Alliance Healthcare (Distribution) Ltd)
Doxazosin 4mg tablets (Almus Pharmaceuticals Ltd)
Doxazosin 4mg tablets (Bristol Laboratories Ltd)
Doxazosin 4mg tablets (Dexcel-Pharma Ltd)
Doxazosin 4mg tablets (Ennogen Healthcare International Ltd)
Doxazosin 4mg tablets (Medihealth (Northern) Ltd)
Doxazosin 4mg tablets (Medreich Plc)
Doxazosin 4mg tablets (Milpharm Ltd)
Doxazosin 4mg tablets (Phoenix Healthcare Distribution Ltd)
Doxazosin 4mg tablets (Relonchem Ltd)
Doxazosin 4mg tablets (Sigma Pharmaceuticals Plc)
Doxazosin 4mg tablets (Teva UK Ltd)
Virtual Medicinal Product Packs
Doxazosin 4mg tablets 28 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback